Zonegran
Sponsors
Eisai GmbH, Tuscaloosa Research & Education Advancement Corporation, Eisai Limited, Lindner Center of HOPE, Dr. Reddy's Laboratories Limited
Conditions
Binge Eating Disorder Associated With ObesityDyskinesiasEpilepsyHealthyMyoclonus DystoniaObesityParkinson DiseaseParkinsonism
Phase 1
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
CompletedNCT01161966
Start: 2005-01-31End: 2005-03-31Updated: 2010-07-14
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
CompletedNCT01161979
Start: 2005-01-31End: 2005-03-31Updated: 2010-07-14
Phase 3
Phase 4
Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization
TerminatedNCT00165828
Start: 2005-05-31End: 2008-02-29Updated: 2014-06-27
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
CompletedNCT00203450
Start: 2003-05-31End: 2006-03-31Updated: 2012-09-03
Open Label, Zonegran (Zonisamide) In Partial Onset Seizures
CompletedNCT00215592
Start: 2005-10-31Updated: 2016-01-08
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease
SuspendedNCT03034538
Start: 2016-04-08End: 2022-12-31Target: 20Updated: 2021-11-23